CIK 0001439222 · Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- 4 Planned sale Chief Legal Officer sold 5,218 shares at $28.96 ($151,113)
- 4 Planned sale Chief Medical Officer sold 4,055 shares at $28.96 ($117,433)
- 4 Planned sale Chief Financial Officer sold 5,035 shares at $28.96 ($145,814)
- 4 Planned sale Chief Commercial Officer sold 2,868 shares at $28.96 ($83,057)
- 4 Planned sale Principal Accounting Officer sold 2,223 shares at $28.96 ($64,378)
- 4 Derivatives Options or other derivatives
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- S-3ASR Offering Registration Statement
- 10-K Report Annual Report
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Regulation FD disclosure
- 4 Planned sale Chief Commercial Officer sold 2,872 shares at $27.02 ($77,601)
- 144 Insider Sale of Securities
Page 4 of 66 · 1,304 filings